All Outputs (5)

De novo thyroid eye disease following COVID vaccination several years after radioiodine therapy (2025)
Journal Article
Mukunda, A., James, J., Jacob, R., Varughese, G. I., & Nayak, A. U. (in press). De novo thyroid eye disease following COVID vaccination several years after radioiodine therapy. JRSM Open, 16(1), https://doi.org/10.1177/20542704241304220

Lesson: The delayed onset of thyroid eye disease is well recognised but less commonly perceived in routine clinical practice and this case report serves as a reminder for a high index of suspicion in at-risk patients.

PCSK9 levels and diabetic retinopathy: opportunities for a potential target and novel therapeutic approach in conjunction with treating dyslipidaemia. (2024)
Journal Article
Varughese, M. S., Nayak, A. U., & Jacob, S. (in press). PCSK9 levels and diabetic retinopathy: opportunities for a potential target and novel therapeutic approach in conjunction with treating dyslipidaemia. Eye, 1-3. https://doi.org/10.1038/s41433-024-03523-1

Idiopathic intracranial hypertension: Evolving trends of weight management with newer incretin mimetics and options for precision medicine in obesity (2024)
Journal Article
Varughese, M. S., & Nayak, A. U. (in press). Idiopathic intracranial hypertension: Evolving trends of weight management with newer incretin mimetics and options for precision medicine in obesity. Eye, https://doi.org/10.1038/s41433-024-03426-1

Letter to the Editor: PCSK9 Inhibitors and Lipid Lowering: Viewpoint on Diabetic Retinopathy (2024)
Journal Article
Varughese, M. S., & Nayak, A. U. (2024). Letter to the Editor: PCSK9 Inhibitors and Lipid Lowering: Viewpoint on Diabetic Retinopathy. OSLIRetina, 1-2. https://doi.org/10.3928/23258160-20241101-05

Fenofibrate therapy in reducing the progression of diabetic retinopathy: revisiting the FIELD and ACCORD-EYE studies through the LENS trial. (2024)
Journal Article
Varughese, M. S., Nayak, A. U., & Jacob, S. (in press). Fenofibrate therapy in reducing the progression of diabetic retinopathy: revisiting the FIELD and ACCORD-EYE studies through the LENS trial. Eye, https://doi.org/10.1038/s41433-024-03410-9